摘要
O-异戊烯基香豆素(3,3-二甲基烯丙基,香叶基 - ,法呢基和相关的生物合成衍生物)代表一类很少发生的天然产物。 在过去的二十年中,已经发现这种次级代谢物具有有希望的和有效的药理学性质,主要是在抗癌和抗炎特性方面。 迄今为止,已经从植物,真菌和细菌中提取了大约160个羟苯丙酮香豆素。 柑橘属已被证明是最丰富的标题产品之一。 这篇全面综述的目的是对迄今为止报道的关于从植物化学和药理学观点来看在该属中发现的主要O-异戊烯基香豆素的文献引用进行调查,并且迄今未报道的文献中没有对其进行调查 制作。
关键词: 柑橘属。 香豆素,呋喃香豆素,氧化烯丙基化次级代谢物,苯丙素,芸香科,真菌,细菌。
Current Medicinal Chemistry
Title:Prenylated Coumarins of the Genus Citrus: An Overview of the 2006- 2016 Literature Data
Volume: 25 Issue: 10
关键词: 柑橘属。 香豆素,呋喃香豆素,氧化烯丙基化次级代谢物,苯丙素,芸香科,真菌,细菌。
摘要: O-Prenyl coumarins (3,3-dimethylallyl, geranyl-, farnesyl- and related biosynthetic derivatives) represent a class of rarely occurring natural products. In the last two decades, such secondary metabolites have been found to possess promising and effective pharmacological properties, mainly in terms of anti-cancer and anti-inflammatory properties. To date, about 160 oxyprenylated coumarins have been extracted from plants, fungi, and bacteria. The genus Citrus has been demonstrated to be among the richest source of the title products. The aim of this comprehensive review is to make a survey of the so far reported literature citations about the main O-prenyl coumarins found in this genus from phytochemical and pharmacological point of views and for which no surveys of the in so far reported literature have been made.
Export Options
About this article
Cite this article as:
Prenylated Coumarins of the Genus Citrus: An Overview of the 2006- 2016 Literature Data, Current Medicinal Chemistry 2018; 25 (10) . https://dx.doi.org/10.2174/0929867325666180104154443
DOI https://dx.doi.org/10.2174/0929867325666180104154443 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery Body Mass Index, Lipid Metabolism and Estrogens: Their Impact on Coronary Heart Disease
Current Medicinal Chemistry Regulation of Multidrug Resistance by Pro-Inflammatory Cytokines
Current Cancer Drug Targets Pyrroles and Fused Pyrroles: Synthesis and Therapeutic Activities
Mini-Reviews in Organic Chemistry The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry Preface
Current Cancer Drug Targets Bioactive Natural Products from the Antarctic and Arctic Organisms
Mini-Reviews in Medicinal Chemistry The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Current Drug Delivery Anti-GD2 Antibody Therapy for GD2-Expressing Tumors
Current Cancer Drug Targets In Vivo Inhibition of the Estrogen Sulfatase Enzyme and Growth of DMBA-Induced Mammary Tumors by Melatonin
Current Cancer Drug Targets Overexpression of RAD50 is the Marker of Poor Prognosis and Drug Resistance in Breast Cancer Patients
Current Cancer Drug Targets Diet Bioactive Compounds: Implications for Oxidative Stress and Inflammation in the Vascular System
Endocrine, Metabolic & Immune Disorders - Drug Targets Peripheral and Central Glutamate Dyshomeostasis in Neurodegenerative Disorders
Current Neuropharmacology Recent Advances in Medicinal Applications of Coinage-Metal (Cu and Ag) N-Heterocyclic Carbene Complexes
Current Topics in Medicinal Chemistry Aryl Butenes Active against K562 Cells and Lacking Tyrosinase Inhibitory Activity as New Leads in the Treatment of Leukemia
Mini-Reviews in Medicinal Chemistry Novel Therapeutic Strategy in the Management of COPD: A Systems Medicine Approach
Current Medicinal Chemistry Heparan Sulphate as a Regulator of Leukocyte Recruitment in Inflammation
Current Protein & Peptide Science Non-Melanoma Skin Cancer – Overview
Current Cancer Therapy Reviews Potential Cardio-Protective Agents: A Resveratrol Review (2000-2019)
Current Pharmaceutical Design Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Current Cancer Drug Targets